Pasar al contenido principal

SISTEMAS INNOVADORES PARA LA LIBERACION CONTROLADA DE FARMACOS, DETECCION DE ROS Y MONITORIZACION AVANZADA EN TERAPIAS CONTRA EL CANCER

PID2024-161273OB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optimizing liposomal drug release via γ-irradiation and iron-based radiosensitization

  • Loscertales, E.
  • España, Samuel
Chemotherapy remains a cornerstone of cancer treatment, yet its lack of tumor specificity often leads to systemic toxicity and limits the maximum tolerable dose. To address these limitations, drug-loaded nanocarriers responsive to ionizing radiation have emerged as a promising strategy to achieve localized drug release within irradiated tumor regions, thereby enhancing therapeutic efficacy while minimizing off-target effects. However, current radiation-responsive nanosystems often exhibit limited drug release at clinically relevant radiation doses. In our previous work, we evaluated liposomal formulations varying lipid composition, sensitizers, and particle size. While these systems demonstrated moderate immediate release upon irradiation followed by sustained passive leakage, they were incompatible with remote drug loading and failed to achieve rapid release. In the present study, we optimized the liposomal membrane composition through modulation of polyunsaturated and saturated phospholipids to enhance radiation sensitivity and colloidal stability. Furthermore, we introduced a radiosensitization mechanism based on the encapsulation of Fe³+ ions, which are reduced to Fe2+ upon γ-irradiation. This redox transition triggers a Fenton-like reaction that catalyzes the degradation of lipid hydroperoxides, leading to localized lipid peroxidation and membrane disruption. This dual strategy, membrane composition tuning and iron-mediated oxidative activation, resulted in significantly enhanced drug release upon exposure to low-dose radiation., This work was funded by the Spanish MCIN/AEI/10.13039/501100011033 through the NANORADIOTHER project (PID2021-127033OB-C22) and the NANOFIGHT project (PID2024-161273OB-C22); by the Comunidad de Madrid through the ASAP-CM project (S2022/BMD-7434); and by the TRANSCAN2024-2930-142_XPANTHER project, funded by the Instituto de Salud Carlos III and the Asociación Española Contra el Cáncer (AECC). It also received support within the framework of the LUNABRAIN-CM project, funded with €1.026 million by the Comunidad de Madrid through the R&D activities program in technologies, granted by Order 5696/2024. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN, and the Pro CNIC Foundation, and is recognized as a Severo Ochoa Center of Excellence (grant CEX2020-001041-S, funded by MICIN/AEI/10.13039/501100011033)., Peer reviewed